Uscom Share Price and Company Fundamentals



Price
$0.012
Change
0.000 (0.000%)
52 week range
0.011 - 0.03

Last traded: 09/23/2025

Uscom Limited designs, develops, manufactures, and markets non-invasive cardiovascular and pulmonary medical devices in Australia, Asia, the Americas, and Europe. It offers USCOM 1A, a non-invasive hemodynamic monitor that measures blood flow, stroke volume, and cardiac output; and BP+, a supra-systolic oscillometric central blood pressure monitor that measures blood pressure and blood pressure waveforms at the heart, as well as in the arm. The company also provides the SpiroSonic Ultrasonic spirometer, a pulmonary function testing device that uses multi-path ultrasound; SpiroSonic FLO and SpiroSonic AIR, a digital multi-path ultrasonic spirometer for pulmonary function diagnostic and monitoring COPD and asthma; and SpiroSonic SMART for use by general practitioners and patients for screening COPD and asthma. It serves hospitals and medical care locations through its distribution partners. The company was formerly known as Uscom Pty Limited and changed its name to Uscom Limited in October 2003. The company was incorporated in 1999 and is headquartered in Sydney, Australia.

Key Metrics

PE ratio

-

PB ratio

-

Dividend yield

-

Beta

-1.50

Market cap

$3.12M

Enterprise value

$4.42M

Company profile

Industry / Sector Medical Devices / Healthcare
Website https://www.uscom.com.au
Mailing address 66 Clarence Street Suite 2 Level 8 Sydney NSW 2000 Australia
Phone / Fax 61 2 9247 4144 / 61 2 9247 8157

Dividends

More: Uscom Dividend history, yield and payout ratio

Dividend yield

-

Dividend amount

$-

Payout ratio

0.00%

5Y Avg. yield

-%

Uscom paid $- dividend and the ex-dividend date was -.The dividend payout ratio is 0.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.UCM dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.

Company Executives

As of Feb 2026, following are the company executives and directors listed on Uscom.

Name Title Age Total Pay
Dr. Robert Allan Phillips AMS, DMU, FASE, FIR, MPhil (Med), Ph.D.(Med) Founder, Executive Chairman, CEO & Chief Scientist 72
Mr. Brett Thomas Crowley B.Com., C.A., DipLaw Company Secretary & Independent Non-Executive Director 68
Mr. Nicholas Schicht BEng General Manager 59

Profitability and management effectiveness

Profit margin

-128.07%

Operating margin

-241.18%

Return on assets

-42.61%

Return on equity

-218.52%

Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.

The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.

Valuation and Trading Info

The market capitalization of Uscom is 3.12M and its enterprise value is 4.42M. The enterprise value to revenue ratio of UCM is 1.71. The enterprise value to EBITDA ratio of UCM is -1.63.

Companies similar to Uscom (UCM)

Uscom (ASX:UCM) Frequently Asked Questions

1. What is Uscom's Stock Symbol?

Uscom trades on ASX under the ticker symbol "UCM".

2. What is Uscom's stock price today?

One share of UCM stock can currently be purchased for approximately $0.012.

3. How can I contact Uscom?

Uscom's mailing address is 66 Clarence Street Suite 2 Level 8 Sydney NSW 2000 Australia. The company can be reached via phone at 61 2 9247 4144.

4. What is Uscom's official website?

The official website of Uscom is https://www.uscom.com.au.